Replies to post #135051 on Vivos Inc (RDGL)

[SC8]

Agreed, but the criteria for STeP approval is ".....reasonably expected to significantly improve the safety of currently available treatments........". That's why I think RDGL doing a STeP application has low odds of success. Going the slower conventional FDA route is the wiser choice IMHO.